EUVIMEDEUVIMED entdecken
Crossref

Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge

Sibi Das

Advances in Diabetes & Endocrinology · 2026 · 9 (1)

DOI: 10.13188/2475-5591.1000026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Diabetes & Endocrinology, 2026. Verfasst von Sibi Das.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency characterized by insulin deficiency, ketonemia, and high-anion gap metabolic acidosis.Although traditionally associated with type 1 diabetes, DKA is increasingly recognized in Type 2 Diabetes Mellitus, particularly in the context of evolving therapies and metabolic stress.A notable shift in recent years is the emergence of euglycemic diabetic ketoacidosis (euDKA), defined as DKA with blood glucose levels

Zitieren

APA

Das, S. (2026). Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge. Advances in Diabetes & Endocrinology, 9(1). https://doi.org/10.13188/2475-5591.1000026

Vancouver

Das S. Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge. Advances in Diabetes & Endocrinology. 2026;9(1). doi:10.13188/2475-5591.1000026

BibTeX
@article{Das2026,
  author = {Das, Sibi},
  title = {Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge},
  journal = {Advances in Diabetes & Endocrinology},
  year = {2026},
  volume = {9},
  number = {1},
  doi = {10.13188/2475-5591.1000026}
}
Kostenlos starten →